GlassScriptPhysician profile
Nataliya Biskup
NPI 1225353014
$2,209.39
in general payments reported to CMS, 2019-2025
20 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $79.75 · 2021: $466 · 2022: $340 · 2023: $502 · 2024: $395 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $663.83 | 2021-2025 | Trumatch, Na |
| Tela Bio, INC. | $297.68 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $266.78 | 2019-2022 | |
| Galderma Laboratories, L.P. | $234.30 | 2021-2024 | Dysport |
| Sientra, INC. | $156.22 | 2020-2021 | |
| Abbvie INC. | $105.02 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Vertex Pharmaceuticals Incorporated | $79.21 | 2025 | |
| Smith+Nephew, INC. | $76.86 | 2019-2024 | Grafix Pl, Oasis |
| Mentor Worldwide LLC | $76.75 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $48.11 | 2022 | |
| Integra Lifesciences Corporation | $44.04 | 2022-2023 | Durasorb Monofilament Mesh |
| Pacira Pharmaceuticals Incorporated | $29.72 | 2021 | |
| Stryker Corporation | $24.11 | 2024 | Deaver |
| Polynovo North America LLC | $23.75 | 2024 | Novosorb Btm |
| Innovation Technologies INC | $23.37 | 2024 | Irrisept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $17.27 | 2019 | |
| Solventum Corporation | $15.98 | 2024 | V.A.C.Ulta, Activ.A.C. |
| Solta Medical, A Division of Bausch Health US, LLC | $13.90 | 2021 | |
| Medline Industries LP | $12.49 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nataliya Biskup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.